A targeted therapy that inhibits RET kinase, used in cancers with RET gene alterations. It disrupts signaling pathways essential for tumor cell survival and proliferation. Approved for certain types of thyroid and lung cancers.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Selpercatinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Selpercatinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Selpercatinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
